FT Latin America Healthcare & Life Sciences Summit

International companies are expanding aggressively in Latin America in a bid to tap rising healthcare spending by an expanding middle class. Longer life-expectancy and rising popular expectations are putting long-established publically funded healthcare systems under growing pressure and creating opportunity for private providers as increasing numbers of Latin American’s look for private care, either through private insurance or the purchase of healthcare services. Latin America’s pharmaceutical industry, meanwhile, is experiencing rapid growth as countries move from a predominance of infectious, poverty-related diseases to lifestyle and ageing-related diseases that require more sophisticated drugs and treatments.